The Future of Gene Editing
The emergence of CRISPR as a catalyst for gene editing has hurled open a door to new advances in biotechnology and medicine. While the scientific community has been debating and applying CRISPR in various lab settings, the transition to real-world applications is imminent, taking place with no clear policy on guidelines or potential restrictions.
The Future of Gene Editing will be a multi-disciplinary panel discussion on policy considerations for gene editing implementation, with emphasis on long term societal implications.
We will have four exceptional speakers:
– JAMIE METZL, Senior Fellow of the Atlantic Council, novelist, blogger, syndicated columnist, media commentator, and expert in Asian affairs and biotechnology policy.
– WENDY CHUNG, Diirector of the Clinical Genetics program of Columbia University, Hervert Irving Associate Professor of Pediatrics.
– S. MATTHEW LIAO, Arthur Zitrin Chair in Bioethics and Director for The Center for Bioethics at New York University.
– ROBBIE BARBERO, Assistant Director for Biological Innovation, White House, Office of Science and Technology Policy.